SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-08-078768
Filing Date
2008-04-10
Accepted
2008-04-10 12:47:40
Documents
6
Period of Report
2008-05-18
Effectiveness Date
2008-04-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE NOTICE AND PROXY STATEMENT ddef14a.htm DEF 14A 223663
2 GRAPHIC g21730fsc_logo.jpg GRAPHIC 12093
3 GRAPHIC g21730g01u55.jpg GRAPHIC 6486
4 GRAPHIC g21730g38g72.jpg GRAPHIC 7189
5 GRAPHIC g21730g41a80_v1.jpg GRAPHIC 17244
6 GRAPHIC g21730g41a80_v2.jpg GRAPHIC 11398
  Complete submission text file 0001193125-08-078768.txt   301039
Mailing Address 22118 20TH AVE SE SUITE 204 BOTHELL WA 98021
Business Address 22118 20TH AVE SE SUITE 204 BOTHELL WA 98021 425 402 8400
HELIX BIOMEDIX INC (Filer) CIK: 0000831749 (see all company filings)

IRS No.: 912099117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 033-20897 | Film No.: 08749425
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1